🔗 Visit the ClinicalTrials.gov page for NCT01132482
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Preclinical evidence that sildenafil and vardenafil activate chloride transport in cystic fibrosis. | Am J Respir Crit Care Med | 2007 | 2.18 |
| 2 | Structural analog of sildenafil identified as a novel corrector of the F508del-CFTR trafficking defect. | Mol Pharmacol | 2007 | 1.25 |
| 3 | Sildenafil (Viagra) corrects DeltaF508-CFTR location in nasal epithelial cells from patients with cystic fibrosis. | Thorax | 2005 | 0.98 |
| 4 | Pharmacological modulation of cGMP levels by phosphodiesterase 5 inhibitors as a therapeutic strategy for treatment of respiratory pathology in cystic fibrosis. | Am J Physiol Lung Cell Mol Physiol | 2007 | 0.86 |
| 5 | Endosomal hyperacidification in cystic fibrosis is due to defective nitric oxide-cylic GMP signalling cascade. | EMBO Rep | 2006 | 0.86 |
| 6 | Pharmacokinetics and tolerability of oral sildenafil in adults with cystic fibrosis lung disease. | J Cyst Fibros | 2014 | 0.77 |